Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PJT Partners (PJT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Partners (PJT) over the last 12 years, with Q3 2025 value amounting to $400.5 million.

  • Partners' Cash & Equivalents rose 16905.59% to $400.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $400.5 million, marking a year-over-year increase of 16905.59%. This contributed to the annual value of $483.9 million for FY2024, which is 3609.52% up from last year.
  • Latest data reveals that Partners reported Cash & Equivalents of $400.5 million as of Q3 2025, which was up 16905.59% from $214.6 million recorded in Q2 2025.
  • In the past 5 years, Partners' Cash & Equivalents registered a high of $483.9 million during Q4 2024, and its lowest value of $75.8 million during Q1 2022.
  • Its 5-year average for Cash & Equivalents is $201.3 million, with a median of $173.2 million in 2022.
  • As far as peak fluctuations go, Partners' Cash & Equivalents tumbled by 3886.92% in 2023, and later surged by 16905.59% in 2025.
  • Quarter analysis of 5 years shows Partners' Cash & Equivalents stood at $200.5 million in 2021, then fell by 13.59% to $173.2 million in 2022, then surged by 105.24% to $355.5 million in 2023, then soared by 36.1% to $483.9 million in 2024, then fell by 17.24% to $400.5 million in 2025.
  • Its last three reported values are $400.5 million in Q3 2025, $214.6 million for Q2 2025, and $194.3 million during Q1 2025.